BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38827222)

  • 1. Case Report: Micafungin for treating
    Parramon-Teixido CJ; Garcia Esquerda C; Frick MA; Tripodi C; Gomez-Ganda L; Ruiz-Campillo CW; Cabañas-Poy MJ
    Front Pediatr; 2024; 12():1397456. PubMed ID: 38827222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the use of micafungin in newborns].
    Çakır SÇ; Çelebi S; Özkan H; Köksal N; Dorum BA; Yeşil E; Hacımustafaoğlu M
    Mikrobiyol Bul; 2019 Jan; 53(1):70-80. PubMed ID: 30683041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Candida urinary tract infections with micafungin in children.
    Ekinci F; Yildizdas D; Horoz OO; Ozgur Gundeslioglu O; Alabaz D
    Pediatr Int; 2022 Jan; 64(1):e15033. PubMed ID: 35146837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of micafungin in treating four premature infants with candidiasis.
    Kawaguchi C; Arai I; Yasuhara H; Sano R; Nishikubo T; Takahashi Y
    Pediatr Int; 2009 Apr; 51(2):220-4. PubMed ID: 19405920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating
    Schrevens S; Sanglard D
    J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.
    Grau S; Luque S; Echeverría-Esnal D; Sorlí L; Campillo N; Montero M; Álvarez Lerma F; Plasencia V; Horcajada JP
    Int J Antimicrob Agents; 2016 Aug; 48(2):212-4. PubMed ID: 27424599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Neonatal Non- albicans Candidiasis: Autopsy Study and Literature Review.
    Hemedez C; Trail-Burns E; Mao Q; Chu S; Shaw SK; Bliss JM; De Paepe ME
    Pediatr Dev Pathol; 2019; 22(2):98-105. PubMed ID: 30193562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain Distribution and Drug Susceptibility of Invasive Fungal Infection in Clinical Patients With Systemic Internal Diseases.
    Zeng X; Peng M; Liu G; Huang Y; Zhang T; Wen J; Lai W; Zheng Y
    Front Bioeng Biotechnol; 2020; 8():625024. PubMed ID: 33644009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of candiduria with micafungin: A case series.
    Lagrotteria D; Rotstein C; Lee CH
    Can J Infect Dis Med Microbiol; 2007 Mar; 18(2):149-50. PubMed ID: 18923769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on candiduria in neonates and infants from a tertiary care center, North India.
    Yadav RK; Singh G; Kiran KS; Iram A; Rana B; Cs S; Xess I
    Indian J Med Microbiol; 2023; 42():25-29. PubMed ID: 36967211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sepsis caused by Candida in the neonatal period].
    Padovani EM; Michielutti F; Dall'Agnola A; Dal Moro A; Khoory BJ
    Pediatr Med Chir; 1997; 19(2):83-8. PubMed ID: 9312755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis.
    Bienvenu AL; Leboucher G; Picot S
    Mycoses; 2019 Sep; 62(9):835-846. PubMed ID: 31077631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
    Fridkin SK; Kaufman D; Edwards JR; Shetty S; Horan T
    Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice.
    Schrevens S; Torelli R; Sanguinetti M; Sanglard D
    Methods Mol Biol; 2023; 2658():239-247. PubMed ID: 37024707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.